RZLT
Rezolute, Inc.NASDAQHealthcare$3.12-0.32%ClosedMarket Cap: $298.6M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
2.53
P/S
0.00
EV/EBITDA
-3.26
DCF Value
$1.15
FCF Yield
-25.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-64.8%
ROA
-60.8%
ROIC
-69.3%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q2 2026 | $0.00 | -Infinity% | $-24.2M | $-22.8M | $-0.22 | — |
| Q1 2026 | $0.00 | -Infinity% | $-19.8M | $-18.1M | $-0.18 | — |
| Q4 2025 | $0.00 | NaN% | $-25.9M | $-24.4M | $-0.26 | — |
| FY 2025 | $0.00 | NaN% | $-79.9M | $-74.4M | $-0.98 | — |
| Q3 2025 | $0.00 | NaN% | $-20.0M | $-18.9M | $-0.27 | — |
| Q2 2025 | $0.00 | NaN% | $-17.1M | $-15.7M | $-0.22 | — |
| Q1 2025 | $0.00 | NaN% | $-16.9M | $-15.4M | $-0.22 | — |
| Q4 2024 | $0.00 | NaN% | $-23.1M | $-23.0M | $-0.45 | — |
| FY 2024 | $0.00 | NaN% | $-70.4M | $-68.5M | $-1.33 | — |
| Q3 2024 | $0.00 | -Infinity% | $-16.2M | $-17.1M | $-0.34 | — |
| Q2 2024 | $0.00 | -Infinity% | $-15.2M | $-13.9M | $-0.27 | — |
| Q1 2024 | $0.00 | NaN% | $-15.9M | $-14.5M | $-0.28 | — |